TITLE

New drugs and dosage forms

PUB. DATE
August 2010
SOURCE
American Journal of Health-System Pharmacy;8/1/2010, Vol. 67 Issue 15, p1220
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information on various drugs and its dosage which include dutasteride and tamsulosin capsules for men with symptomatic benign prostatic hyperplasia, lacomaside oral solution with strawberry fruit flavor, and memantine hydrochloride capsules taken every day.
ACCESSION #
52449197

 

Related Articles

  • Oral drug approved for relapsing multiple sclerosis. Thompson, Cheryl A. // American Journal of Health-System Pharmacy;11/1/2010, Vol. 67 Issue 21, p1788 

    The article reports on the approval of Novartis AG's fingolimod, a podrug of sphingosine 1-phosphate receptor modulator, for treating patients with relapsing forms of multiple sclerosis by the U.S. Food & Drug Administration (FDA). It looks at how such drug aids in reducing the severity of...

  • Did I pour the right dose of medicine? Onderko, Patty // Parenting Early Years;May2011, Vol. 25 Issue 4, p30 

    The article offers advice about giving children the right dosage of medicine by purchasing own measuring devices like dropper, cup or dosing spoon, not using kitchen spoons as substitute for teaspoons or tablespoons, and asking pediatrician if having a trouble in figuring out how much medicine...

  • Alfuzosin hydrochloride for the treatment of benign prostatic hyperplasia. Lee, Mary // American Journal of Health-System Pharmacy;7/15/2003, Vol. 60 Issue 14, p1426 

    The chemistry, pharmacology, pharmacokinetics, clinical efficacy, and adverse effects of alfuzosin hydrochloride in the treatment of benign prostatic hyper-plasia (BPH) are discussed. Alfuzosin is a functionally uroselective α[SUB1]-adrenergic antagonist indicated for the) management of...

  • Phase I study of an oral formulation of irinotecan administered daily for 14 days every 3 weeks in patients with advanced solid tumours. Schoemaker, Nadja E.; Kuppens, I. E. L. M.; Ten Bokkel Huinink, Wim W.; Lefebvre, Patricia; Beijnen, Jos H.; Assadourian, Sylvie; Sanderink, Ger-Jan; Schellens, Jan H. M.; Huinink, Wim W Ten Bokkel // Cancer Chemotherapy & Pharmacology;Mar2005, Vol. 55 Issue 3, p263 

    A phase I study was conducted with oral irinotecan given daily for 14 days every 3 weeks in 45 patients with solid tumours to establish the maximum tolerated dose (MTD), toxicity, preliminary antitumour response and pharmacokinetics. Irinotecan was administered orally as a powder-filled capsule...

  • Pharmacokinetics of Oral Prulifloxacin Capsules in Healthy Volunteers. Jing Zou; Lu Chen; Jiying Yu; Lin He; Hongtao Xiao; Jinqi Li; Yuan Bian; Rongsheng Tong; Zhengzhong Wu // Journal of Algorithms & Computational Technology;Mar2011, Vol. 5 Issue 1, p111 

    The main objective of this paper is to investigate the pharmacokinetics of NM394 (an active metabolite of prulifloxacin) and evaluate the dose relationship and accumulation characteristics after single and multiple doses of prulifloxacin. Thirty healthy volunteers were given 132 mg, 264 mg, and...

  • Can Statins Benefit Patients with Multiple Sclerosis? Walling, Anne D. // American Family Physician;3/1/2005, Vol. 71 Issue 5, p995 

    Discusses research being done on the effectiveness of oral simvastatin treatment in relapsing-remitting multiple sclerosis. Reference to a study by T Vollmer et al published in the May 15, 2004 issue of "Lancet"; Effect of statins on cholesterol levels; Dosage of simvastatin needed to have a...

  • Prescribing liquid medication: can the dose be accurately given? Morecroft, Charles W.; Caldwell, Neil A.; Gill, Andrea // Archives of Disease in Childhood;Oct2013, Vol. 98 Issue 10, p831 

    The article offers information on the research related to prescription of liquid medication and dosing errors. It mentions that dosing errors are the most common type of errors in liquid medications prescribed to paediatric and neonatal inpatients. As per the study one in eight prescribed doses...

  • Plecanatide, an Oral Guanylate Cyclase C Agonist Acting Locally in the Gastrointestinal Tract, Is Safe and Well-Tolerated in Single Doses. Shailubhai, Kunwar; Comiskey, Stephen; Foss, John; Feng, Rong; Barrow, Laura; Comer, Gail; Jacob, Gary // Digestive Diseases & Sciences;Sep2013, Vol. 58 Issue 9, p2580 

    Purpose: Plecanatide, an analogue of uroguanylin, activates the guanylate cyclase C (GC-C) receptor found on the GI mucosal epithelial cells, leading to secretion of fluid, facilitating bowel movements. Plecanatide is being investigated as a potential treatment for constipating GI disorders. The...

  • Functionalized Calcium Carbonate as a Novel Pharmaceutical Excipient for the Preparation of Orally Dispersible Tablets. Stirnimann, Tanja; Maiuta, Nicola; Gerard, Daniel; Alles, Rainer; Huwyler, Jörg; Puchkov, Maxim // Pharmaceutical Research;Jul2013, Vol. 30 Issue 7, p1915 

    Purpose: To overcome the limitation of insufficient hardness during the production of rapidly disintegrating orally dispersible tablets (ODTs). Furthermore, we investigated the properties and usefulness of functionalized calcium carbonate (FCC) as a new pharmaceutical excipient for the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics